Imatinib dispensed and purchased in calendar year 2021
Thank you for your request dated 4 April 2022 under the Official Information Act 1982 (OIA) for information relating to imatinib. You requested:
The total quantities of Imatinib Mesilate as funded by Pharmac for the most recent twelve month period.
- Imatinib-Rex Cap 100mg 2594315 per 60
- Imatinib-Rex Cap 400mg 2594323 per 30
- Glivec (Novartis) Tab 100mg 2123606 per 60
Please find data for your request provided within the tables below.
Table 1: Number of packs dispensed in the community between 1 January to 31 December 2021
| Brand | Formulation | Calendar year | Packs dispensed |
|---|---|---|---|
| Glivec | Tab 100 mg | 2021 | 1,436 |
| Imatinib-Rex | Cap 100 mg | 2021 | 2,057 |
| Imatinib-Rex | Cap 400 mg | 2021 | 2,981 |
Table 2: Number of packs purchased in DHB hospitals between 1 January to 31 December 2021
| Brand | Formulation | Calendar year | Packs purchased |
|---|---|---|---|
| Imatinib-Rex | Cap 100 mg | 2021 | 18 |
| Imatinib-Rex | Cap 400 mg | 2021 | 12 |
Note: Figures in Table 2 are based on purchase data provided by DHBs. Pharmac makes no representation as to the accuracy of the figures provided.
We trust that this information answers your queries. We are making our information more freely available, so we now publish selected OIA responses (excluding personal details) on our website. Please get in touch with us if you have any questions about this.